1799 GENE EXPRESSION PROFILES OF LYMPHOCYTES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCC) TREATED WITH DENDRITIC CELL (DC)-BASED IMMUNOTHERAPY

Thomas Schwaab, Benita Wolf, Adrian Schwarzer, Thomas H. Hampton, Jan L. Fisher, Jiang Gui, John D. Seigne, Marc S. ErnstoffThe Journal of Urology 2010 · DOI

Abstract

You have accessJournal of UrologyKidney Cancer: Advanced II1 Apr 20101799 GENE EXPRESSION PROFILES OF LYMPHOCYTES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCC) TREATED WITH DENDRITIC CELL (DC)-BASED IMMUNOTHERAPY Thomas Schwaab, Benita Wolf, Adrian Schwarzer, Thomas Hampton, Jan Fisher, Jiang Gui, John Seigne, and Marc Ernstoff Thomas SchwaabThomas Schwaab Buffalo, NY More articles by this author , Benita WolfBenita Wolf Hannover, Germany More articles by this author , Adrian SchwarzerAdrian Schwarzer Hannover, Germany More articles by this author , Thomas HamptonThomas Hampton Lebanon, NH More articles by this author , Jan FisherJan Fisher Lebanon, NH More articles by this author , Jiang GuiJiang Gui Lebanon, NH More articles by this author , John SeigneJohn Seigne Lebanon, NH More articles by this author , and Marc ErnstoffMarc Ernstoff Lebanon, NH More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.02.1723AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES In a recent Phase II trial of DC-based immunotherapy (combined with HD IL-2/ IFN-alpha), we reported a 50% overall response rate and significant immunologic effects. We analyzed gene expression profiles of lymphocytes in this patient cohort. METHODS 18 patients with metastatic RCC were enrolled. 9 healthy age-matched donors (HD) served as controls. Lymphocytes were isolated from leukapheresis products prior to treatment and after the induction cycle. RNA was isolated and hybridized on a GeneChip® Human Gene 1.0 ST Array Affymetrix gene chip. A fold change ranking and non-stringent p-value were used to generate gene lists. Groups were compared using student t-test and paired t-test. For hierarchical clustering, data were log transformed and normalized. Ingenuity Pathways Analysis library was used to identify canonical pathways. Genes from the dataset that met the fold change and p-value cutoff were analyzed. Expression of certain target genes (TLRs, IL-2 receptor) was confirmed using standard RT-PCR. RESULTS 9 patients were categorized as responders (R, 3 complete, 6 partial) and 9 as non-responders (NR, 4 stable, 5 progressive disease). In patients, 1455 genes were up and 147 genes were down-regulated with a fold-change (FC)>1.6 and p<0.01, including genes for innate immune system activation, PDGF signaling, immune diseases and post-translational modification. Post-treatment, 136 genes were up- and 217 down-regulated (p<0.05, FC>1.14). Immunotherapy resulted more in down- than in up-regulation of gene expression (antigen processing/ presentation, NK cell cytotoxicity, Cytokine-receptor interaction, cell adhesion molecules). Analysis with Ingenuity pathway analysis revealed 3 altered canonical pathways: T-helper cell differentiation (p: 2.2x10^-5, ratio: 5/38), B-cell receptor signaling (p:6.2x10∧-4, ratio: 7/153), role of NFAT in regulation of the immune response (p: 9.42x10∧-4, ratio: 7/186). Comparing R to NR, 100 genes were upregulated in R and 167 genes were downregulated (p<0.05, FC: 1.2) pre-treatment. Post-treatment, 157 genes were upregulated in R (p<0.05, FC>1.2). Analysis with Ingenuity revealed changes in NK cytotoxicity (7 molecules, p: 0.02) as well as antigen processing and presentation (11 molecules, p<0.0001). CONCLUSIONS This study presents the most comprehensive analysis of the genomic profile of lymphocytes in patients treated with immunotherapy. A number of genes and functional pathways were implicated as potential prognostic and therapeutic targets. © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 183Issue 4SApril 2010Page: e698 Advertisement Copyright & Permissions© 2010 by American Urological Association Education and Research, Inc.MetricsAuthor Information Thomas Schwaab Buffalo, NY More articles by this author Benita Wolf Hannover, Germany More articles by this author Adrian Schwarzer Hannover, Germany More articles by this author Thomas Hampton Lebanon, NH More articles by this author Jan Fisher Lebanon, NH More articles by this author Jiang Gui Lebanon, NH More articles by this author John Seigne Lebanon, NH More articles by this author Marc Ernstoff Lebanon, NH More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
BibTeX
@article{schwaab2010gene,
  author = {Thomas Schwaab and Benita Wolf and Adrian Schwarzer and Thomas H. Hampton and Jan L. Fisher and Jiang Gui and John D. Seigne and Marc S. Ernstoff},
  title = {{1799 GENE EXPRESSION PROFILES OF LYMPHOCYTES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (RCC) TREATED WITH DENDRITIC CELL (DC)-BASED IMMUNOTHERAPY}},
  journal = {The Journal of Urology},
  year = {2010},
  doi = {10.1016/j.juro.2010.02.1723},
}

Loading related content...

Figure